UBS Group’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,188
Closed -$1K 8361
2016
Q3
$1K Sell
1,188
-7,965
-87% -$5.39K ﹤0.01% 7594
2016
Q2
$6K Buy
+9,153
New +$6.48K ﹤0.01% 7085

Other funds holding MATN